JP2005505566A5 - - Google Patents

Download PDF

Info

Publication number
JP2005505566A5
JP2005505566A5 JP2003526937A JP2003526937A JP2005505566A5 JP 2005505566 A5 JP2005505566 A5 JP 2005505566A5 JP 2003526937 A JP2003526937 A JP 2003526937A JP 2003526937 A JP2003526937 A JP 2003526937A JP 2005505566 A5 JP2005505566 A5 JP 2005505566A5
Authority
JP
Japan
Prior art keywords
steroid compound
compound according
hydrogen
therapy
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003526937A
Other languages
English (en)
Japanese (ja)
Other versions
JP4471653B2 (ja
JP2005505566A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/010041 external-priority patent/WO2003022864A1/en
Publication of JP2005505566A publication Critical patent/JP2005505566A/ja
Publication of JP2005505566A5 publication Critical patent/JP2005505566A5/ja
Application granted granted Critical
Publication of JP4471653B2 publication Critical patent/JP4471653B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003526937A 2001-09-12 2002-09-06 ホルモン作用を有する17α−ヒドロキシ−14β−ステロイド Expired - Fee Related JP4471653B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203455 2001-09-12
PCT/EP2002/010041 WO2003022864A1 (en) 2001-09-12 2002-09-06 17alpha-hydroxy-14beta-steroids with hormonal effect

Publications (3)

Publication Number Publication Date
JP2005505566A JP2005505566A (ja) 2005-02-24
JP2005505566A5 true JP2005505566A5 (enExample) 2006-01-05
JP4471653B2 JP4471653B2 (ja) 2010-06-02

Family

ID=8180920

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003526937A Expired - Fee Related JP4471653B2 (ja) 2001-09-12 2002-09-06 ホルモン作用を有する17α−ヒドロキシ−14β−ステロイド

Country Status (28)

Country Link
US (1) US7169769B2 (enExample)
EP (1) EP1427748B1 (enExample)
JP (1) JP4471653B2 (enExample)
KR (1) KR100940054B1 (enExample)
CN (1) CN1257913C (enExample)
AR (1) AR036462A1 (enExample)
AT (1) ATE395352T1 (enExample)
AU (1) AU2002339536B2 (enExample)
BR (1) BR0212409A (enExample)
CA (1) CA2505575C (enExample)
CY (1) CY1108152T1 (enExample)
DE (1) DE60226623D1 (enExample)
DK (1) DK1427748T3 (enExample)
EC (1) ECSP045012A (enExample)
ES (1) ES2305306T3 (enExample)
HR (1) HRP20040193A2 (enExample)
HU (1) HUP0402139A3 (enExample)
IL (2) IL160451A0 (enExample)
IS (1) IS2555B (enExample)
MX (1) MXPA04002418A (enExample)
NO (1) NO326624B1 (enExample)
NZ (1) NZ531487A (enExample)
PL (1) PL207493B1 (enExample)
PT (1) PT1427748E (enExample)
RU (1) RU2294332C2 (enExample)
TW (1) TWI221154B (enExample)
WO (1) WO2003022864A1 (enExample)
ZA (1) ZA200401992B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338925A (en) * 1965-10-25 1967-08-29 Syntex Corp 17-substituted 14beta-estr-4-enes
WO2000053619A1 (en) * 1999-03-08 2000-09-14 Akzo Nobel N.V. 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens
AU4299301A (en) * 2000-02-29 2001-09-12 National University Of Singapore, The A method for modulating steroidogenic activity
US6391868B2 (en) * 2000-05-10 2002-05-21 Lpt Research, Inc. Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Similar Documents

Publication Publication Date Title
JP2008512426A5 (enExample)
RU2002103883A (ru) Перорально активные андрогены
JP2010510210A5 (enExample)
JP2011518845A5 (enExample)
JP2010507685A5 (enExample)
CA2577497A1 (en) 15.beta.-substituted steroids having selective estrogenic activity
NZ586818A (en) Methods and related compositions for reduction of fat
CN1905885A (zh) 包含雌激素和孕激素的延长应用组合
CA2467222A1 (en) Use of estrogenic compounds in combination with progestogenic compounds in hormone-replacement therapy
JP2005533807A5 (enExample)
RU2010100334A (ru) ПРОИЗВОДНОЕ 17β-ЦИАНО-18А-ГОМО-19-НОР-АНДРОСТ-4-ЕНА, ЕГО ПРИМЕНЕНИЕ И ЛЕКАРСТВЕННЫЕ СРЕДСТВА, СОДЕРЖАЩИЕ ПРОИЗВОДНОЕ
RU2001101492A (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ АНДРОСТ-5-EH-3-β, 17β-ДИОЛ, И ЕГО ИСПОЛЬЗОВАНИЕ
DK1272504T3 (da) 8.Beta-hydrocarbylsubstituerede östradiener til anvendelse som selektive östrogener
CN1172949C (zh) 睾酮衍生物
JP2003512474A5 (enExample)
PL1820494T3 (pl) Mikrocząstki składające się z estradiolu i cholesterolu
JP2009512658A5 (enExample)
JP2006507311A5 (enExample)
RU2002117440A (ru) Новые андрогены
JP2003515543A5 (enExample)
JP2003520208A5 (enExample)
JP2002540119A5 (enExample)
JP2005505566A5 (enExample)
RU2010100331A (ru) ПРОИЗВОДНОЕ 17β-ЦИАНО-19-НОР-АНДРОСТ-4-ЕНА, ЕГО ПРИМЕНЕНИЕ И ЛЕКАРСТВЕННЫЕ СРЕДСТВА, СОДЕРЖАЩИЕ УКАЗАННОЕ ПРОИЗВОДНОЕ
JP2002541153A5 (enExample)